InSysBio to present at the ASCPT 2018 Annual Meeting

events
Conference
March 15, 2018

March 12, 2018

InSysBio today announced their participation at AAT-AD/PD Focus Meeting 2018, to be held in Torino, Italy, on March 15-18, 2018. The Meeting is focused on all the latest breakthroughs in treatment and research in Alzheimer’s, Parkinson’s and other neurological diseases. Alexander Stepanov will present “In silico implementation of tauopathy transgenic mouse model” in the framework of session “Symposium 25: Tau in translational studies (2)”.a

March 15, 2018


InSysBio today announced their participation at the ASCPT 2018 Annual Meeting, to be held in Orlando, FL, on March 21-24. Five InSysBio posters will be presented in two poster sessions.


Encore Poster Session (21 March, 5:00 PM – 6:30 PM):

  • “PBPK modeling for therapeutic nanoparticles loaded with drug: distribution and release”
    by Oleg Demin(poster number E-005)

  • “Translational QSP model of amyloid beta allows to predict both short and long term response of AD patients to different therapies”
    by Tatiana Karelina (poster number E-006)



Poster Session II (23 March, 7:00 AM – 8:30 AM):

  • “Multiple myeloma quantitative systems pharmacology model: development and usage for pomalidomide influence evaluation”
    by Svetlana Rubina (poster number PII-115)

  • “Quantitative Systems pharmacology model of bispecific antibodies and CAR-T in acute lymphoblastic leukemia”
    by Oleg Demin Jr (poster number PII-035)

  • “Different tau pathology variants can be described by unique QSP model structure for therapy outcome prediction”
    by Tatiana Karelina (poster number PII-065)

July 2017
MoTuWeThFrSaSu
     
1
2
3
4
5
6
7
8
9
10
11
12
13
14
1. 14 Jul 2017 18:49 To predict unpredictable: a platform for modeling of the high-selective oncology drugs was created Moscow, Russia, July 14, 2017. The scientists from BIND RUS and InSysBio (www.insysbio.ru) published a joint research of the new class of anti-oncology treatment in the Journal of Controlled Release. Unique nanoparticles enriched with medications can deliver its content targeted to the tumor site, and the parameters of their effectiveness are programmed during the forming phase.
15
16
17
18
19
20
21
22
23
24
25
1. 25 Jul 2017 13:50 InSysBio LLC Announce Renewal of Agreement with ASTEX Pharmaceuticals Inc. Moscow, Russia, July 25, 2017 – InSysBio LLC (www.insysbio.ru), one of the pioneers in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development, announced today a renewal of multi-year Master Service Agreement with ASTEX Pharmaceuticals, Inc.
2. 25 Jul 2017 17:37 InSysBio will present at the American Conference on Pharmacometrics (ACoP8)! Moscow, Russia, July 26, 2017. - Event announcement. This year the scientific team of InSysBio will make 9 poster presentations in conjunction with leading pharmaceutical companies at ACoP8. Also at the special session "QSP Modular design - Approaches to speed up the QSP model development" Oleg Demin Jr will hold a workshop on modeling with the Immune Response Template (IRT) platform.
26
27
28
29
30
31
      
Upcoming Events
Tags
Latest News
29.10
InSysBio to announce its collaboration with BeOne Medicines
16.10
InSysBio to introduce a new data annotation service available in CYTOCON DB and fIVE DB
19.08
InSysBio to publish the new article "Revolutionizing drug discovery: Integrating artificial intelligence with quantitative systems pharmacology"
05.08
InSysBio to launch Immune Response Template Open for QSP modeling
25.06
InSysBio to announce extension of collaboration with discoveric bio alpha